BOSTON SCIENTIFIC CORP
BSX · XNYSCIK 885725fmd_1AC21JF054KRBHN1B3G4NVJS6BManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2007 to Sep 30, 2026, 75 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 8,386 | 9,048 | 9,823 | 10,735 | 9,913 | 11,888 | 12,682 | 14,240 | 16,747 | 20,074 |
| Cost of revenue | 2,424 | 2,593 | 2,813 | 3,116 | 3,465 | 3,711 | 3,956 | 4,345 | 5,257 | 6,221 |
| Gross profit | 5,962 | 6,455 | 7,011 | 7,620 | 6,448 | 8,177 | 8,727 | 9,896 | 11,490 | 13,854 |
| Realized investment gains (losses) | (21) | (92) | 155 | (30) | 333 | 250 | (1) | (59) | (79) | 139 |
| Research and development | 920 | 997 | 1,113 | 1,174 | 1,143 | 1,204 | 1,323 | 1,414 | 1,615 | 2,052 |
| Selling, general and administrative | 3,099 | 3,294 | 3,569 | 3,941 | 3,787 | 4,359 | 4,520 | 5,190 | 5,984 | 6,887 |
| Total operating expenses | 5,515 | 5,170 | 5,504 | 6,102 | 6,528 | 6,978 | 7,078 | 7,553 | 8,887 | 10,241 |
| Operating income | 447 | 1,285 | 1,506 | 1,518 | (80) | 1,199 | 1,649 | 2,343 | 2,603 | 3,613 |
| Interest expense | 233 | 229 | 241 | 473 | 361 | 341 | 470 | 265 | 305 | 349 |
| Other non-operating income (expense) | (270) | (353) | (85) | (831) | 1 | (123) | (508) | (358) | (321) | (228) |
| Income before taxes | 177 | 933 | 1,422 | 687 | (79) | 1,076 | 1,141 | 1,985 | 2,282 | 3,385 |
| Income tax expense | (170) | 828 | (249) | (4,013) | 2 | 36 | 443 | 393 | 436 | 493 |
| Net income from continuing operations | 347 | 105 | 1,671 | 4,700 | (81) | 1,040 | 698 | 1,592 | 1,846 | 2,892 |
| Net income | 347 | 104 | 1,671 | 4,700 | (82) | 1,041 | 698 | 1,592 | 1,846 | 2,892 |
| Net income to common shareholders | – | – | 1,671 | 4,700 | (115) | 985 | 642 | 1,570 | 1,853 | 2,898 |